Apyx Medical Corp (APYX)

↓ Download CSV

CIK 0000719135 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Apyx Medical Corp reported revenue of $52.84M, up 9.9% from the prior year. The company ran a net loss, with a net margin of -21.2% and a gross margin of 62.5%. It held $66.84M in total assets against $52.01M in total liabilities.

Key ratios (FY2025)

62.5%
Gross margin
-12.2%
Operating margin
-21.2%
Net margin
-77.1%
Return on equity
+9.9%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$52.84M$48.10M$52.35M$44.51M$48.52M$27.71M$28.23M$16.61M$10.23M
Cost of Revenue$19.80M$18.74M$18.59M$15.38M$14.92M$10.21M$9.14M$5.78M$3.28M$3.70M
Gross Profit$33.04M$29.36M$33.76M$29.13M$33.60M$17.50M$19.09M$10.83M$6.96M$5.12M
Operating Income-$6.45M-$18.84M-$17.26M-$23.56M-$14.45M-$20.08M-$20.87M-$14.28M-$13.88M-$11.39M
Net Income-$11.21M-$23.46M-$18.71M-$23.18M-$15.17M-$11.90M-$19.71M$62.72M-$5.06M-$11.55M
EPS (Diluted)$-0.27$-0.66$-0.54$-0.67$-0.44$-0.35$-0.58$1.89$-0.16$-0.14
Total Assets$66.84M$64.84M$79.24M$51.77M$68.72M$74.11M$84.75M$95.93M$30.99M$35.11M
Total Liabilities$52.01M$50.51M$52.32M$13.98M$14.71M$10.25M$13.49M$8.75M$8.96M$8.89M
Shareholders' Equity$14.54M$14.21M$26.70M$37.58M$53.70M$63.72M$71.26M$87.18M$22.03M$26.22M
Cash & Equivalents$31.74M$31.74M$43.65M$10.19M$30.87M$41.91M$58.81M$16.60M$9.95M$14.46M
Operating Cash Flow-$8.00M-$18.05M-$5.25M-$20.28M-$10.45M-$16.07M-$18.48M-$20.88M-$3.70M-$2.84M
Capital Expenditures$1.11M$722.0K$533.0K$1.01M$723.0K$581.0K$1.30M$363.0K$624.0K$286.0K
Shares Outstanding41.79M37.79M34.64M34.60M34.41M34.29M34.17M33.70M32.88M30.86M